Davies JW et al. |
Pharmacology of capsaicin-, anandamide-, and N-arachidonoyl-dopamine-evoked cell death in a homogeneous transient receptor potential vanilloid subtype 1 receptor population. |
2010 |
Br J Anaesth |
pmid:20354008
|
Jarzimski C et al. |
Changes of blood endocannabinoids during anaesthesia: a special case for fatty acid amide hydrolase inhibition by propofol? |
2012 |
Br J Clin Pharmacol |
pmid:22242687
|
Morgan CJ et al. |
Cerebrospinal fluid anandamide levels, cannabis use and psychotic-like symptoms. |
2013 |
Br J Psychiatry |
pmid:23580381
|
Koethe D et al. |
Anandamide elevation in cerebrospinal fluid in initial prodromal states of psychosis. |
2009 |
Br J Psychiatry |
pmid:19336792
|
Pei R et al. |
Low-fat yogurt consumption reduces biomarkers of chronic inflammation and inhibits markers of endotoxin exposure in healthy premenopausal women: a randomised controlled trial. |
2017 |
Br. J. Nutr. |
pmid:29179781
|
Okine BN et al. |
Lack of effect of chronic pre-treatment with the FAAH inhibitor URB597 on inflammatory pain behaviour: evidence for plastic changes in the endocannabinoid system. |
2012 |
Br. J. Pharmacol. |
pmid:22595021
|
Ho WS and Gardiner SM |
Acute hypertension reveals depressor and vasodilator effects of cannabinoids in conscious rats. |
2009 |
Br. J. Pharmacol. |
pmid:19133994
|
Smart D et al. |
'Entourage' effects of N-acyl ethanolamines at human vanilloid receptors. Comparison of effects upon anandamide-induced vanilloid receptor activation and upon anandamide metabolism. |
2002 |
Br. J. Pharmacol. |
pmid:12023948
|
Kirkham TC et al. |
Endocannabinoid levels in rat limbic forebrain and hypothalamus in relation to fasting, feeding and satiation: stimulation of eating by 2-arachidonoyl glycerol. |
2002 |
Br. J. Pharmacol. |
pmid:12055133
|
Ross RA |
Anandamide and vanilloid TRPV1 receptors. |
2003 |
Br. J. Pharmacol. |
pmid:14517174
|
Vandevoorde S and Fowler CJ |
Inhibition of fatty acid amide hydrolase and monoacylglycerol lipase by the anandamide uptake inhibitor VDM11: evidence that VDM11 acts as an FAAH substrate. |
2005 |
Br. J. Pharmacol. |
pmid:15895107
|
Sun Y et al. |
Cannabinoid activation of PPAR alpha; a novel neuroprotective mechanism. |
2007 |
Br. J. Pharmacol. |
pmid:17906680
|
Malinowska B et al. |
Triphasic blood pressure responses to cannabinoids: do we understand the mechanism? |
2012 |
Br. J. Pharmacol. |
pmid:22022923
|
Ryberg E et al. |
The orphan receptor GPR55 is a novel cannabinoid receptor. |
2007 |
Br. J. Pharmacol. |
pmid:17876302
|
Ross RA et al. |
Structure-activity relationship for the endogenous cannabinoid, anandamide, and certain of its analogues at vanilloid receptors in transfected cells and vas deferens. |
2001 |
Br. J. Pharmacol. |
pmid:11159715
|
Zoratti C et al. |
Anandamide initiates Ca(2+) signaling via CB2 receptor linked to phospholipase C in calf pulmonary endothelial cells. |
2003 |
Br. J. Pharmacol. |
pmid:14645143
|
Price TJ et al. |
Modulation of trigeminal sensory neuron activity by the dual cannabinoid-vanilloid agonists anandamide, N-arachidonoyl-dopamine and arachidonyl-2-chloroethylamide. |
2004 |
Br. J. Pharmacol. |
pmid:15006899
|
Taddei S |
Evolving the concept of regulation of vascular tone in humans. |
2005 |
Br. J. Pharmacol. |
pmid:15997231
|
Mombouli JV et al. |
Anandamide-induced mobilization of cytosolic Ca2+ in endothelial cells. |
1999 |
Br. J. Pharmacol. |
pmid:10323591
|
Hind WH et al. |
Endocannabinoids modulate human blood-brain barrier permeability in vitro. |
2015 |
Br. J. Pharmacol. |
pmid:25651941
|
Woodhams SG et al. |
Spinal administration of the monoacylglycerol lipase inhibitor JZL184 produces robust inhibitory effects on nociceptive processing and the development of central sensitization in the rat. |
2012 |
Br. J. Pharmacol. |
pmid:22924700
|
Akerman S et al. |
Anandamide acts as a vasodilator of dural blood vessels in vivo by activating TRPV1 receptors. |
2004 |
Br. J. Pharmacol. |
pmid:15277315
|
Ameri A et al. |
Effects of the endogeneous cannabinoid, anandamide, on neuronal activity in rat hippocampal slices. |
1999 |
Br. J. Pharmacol. |
pmid:10372827
|
Klegeris A et al. |
Reduction of human monocytic cell neurotoxicity and cytokine secretion by ligands of the cannabinoid-type CB2 receptor. |
2003 |
Br. J. Pharmacol. |
pmid:12813001
|
Thors L and Fowler CJ |
Is there a temperature-dependent uptake of anandamide into cells? |
2006 |
Br. J. Pharmacol. |
pmid:16865094
|
Moreno-Sanz G et al. |
Pharmacological characterization of the peripheral FAAH inhibitor URB937 in female rodents: interaction with the Abcg2 transporter in the blood-placenta barrier. |
2012 |
Br. J. Pharmacol. |
pmid:22774772
|
Van den Bossche I and Vanheel B |
Influence of cannabinoids on the delayed rectifier in freshly dissociated smooth muscle cells of the rat aorta. |
2000 |
Br. J. Pharmacol. |
pmid:10960073
|
Chang L et al. |
Inhibition of fatty acid amide hydrolase produces analgesia by multiple mechanisms. |
2006 |
Br. J. Pharmacol. |
pmid:16501580
|
Thors L et al. |
Inhibition of the cellular uptake of anandamide by genistein and its analogue daidzein in cells with different levels of fatty acid amide hydrolase-driven uptake. |
2007 |
Br. J. Pharmacol. |
pmid:17676056
|
Smart D et al. |
The endogenous lipid anandamide is a full agonist at the human vanilloid receptor (hVR1). |
2000 |
Br. J. Pharmacol. |
pmid:10694225
|
Randall MD et al. |
The complexities of the cardiovascular actions of cannabinoids. |
2004 |
Br. J. Pharmacol. |
pmid:15131000
|
Pakdeechote P et al. |
Cannabinoids inhibit noradrenergic and purinergic sympathetic cotransmission in the rat isolated mesenteric arterial bed. |
2007 |
Br. J. Pharmacol. |
pmid:17641668
|
Al Kury LT et al. |
Effects of the endogenous cannabinoid anandamide on voltage-dependent sodium and calcium channels in rat ventricular myocytes. |
2014 |
Br. J. Pharmacol. |
pmid:24758718
|
Thors L et al. |
The 'specific' tyrosine kinase inhibitor genistein inhibits the enzymic hydrolysis of anandamide: implications for anandamide uptake. |
2007 |
Br. J. Pharmacol. |
pmid:17325653
|
Gardener MJ et al. |
Functional evidence of a role for two-pore domain potassium channels in rat mesenteric and pulmonary arteries. |
2004 |
Br. J. Pharmacol. |
pmid:15066906
|
Fleming I et al. |
Inhibition of the production of endothelium-derived hyperpolarizing factor by cannabinoid receptor agonists. |
1999 |
Br. J. Pharmacol. |
pmid:10193775
|
Romano MR and Lograno MD |
Cannabinoid agonists induce relaxation in the bovine ophthalmic artery: evidences for CB1 receptors, nitric oxide and potassium channels. |
2006 |
Br. J. Pharmacol. |
pmid:16474412
|
Chicca A et al. |
The antinociceptive triterpene β-amyrin inhibits 2-arachidonoylglycerol (2-AG) hydrolysis without directly targeting cannabinoid receptors. |
2012 |
Br. J. Pharmacol. |
pmid:22646533
|
Brighton PJ et al. |
Characterization of the endocannabinoid system, CB(1) receptor signalling and desensitization in human myometrium. |
2011 |
Br. J. Pharmacol. |
pmid:21486283
|
Ruiz-Llorente L et al. |
Characterization of an anandamide degradation system in prostate epithelial PC-3 cells: synthesis of new transporter inhibitors as tools for this study. |
2004 |
Br. J. Pharmacol. |
pmid:14718261
|
Di Marzo V et al. |
The role of endocannabinoids in the regulation of gastric emptying: alterations in mice fed a high-fat diet. |
2008 |
Br. J. Pharmacol. |
pmid:18223666
|
Gardiner SM et al. |
Factors influencing the regional haemodynamic responses to methanandamide and anandamide in conscious rats. |
2009 |
Br. J. Pharmacol. |
pmid:19702785
|
Pertwee RG et al. |
Cross-tolerance between delta-9-tetrahydrocannabinol and the cannabimimetic agents, CP 55,940, WIN 55,212-2 and anandamide. |
1993 |
Br. J. Pharmacol. |
pmid:8306090
|
Evans RM et al. |
Chronic exposure of sensory neurones to increased levels of nerve growth factor modulates CB1/TRPV1 receptor crosstalk. |
2007 |
Br. J. Pharmacol. |
pmid:17700720
|
Wheal AJ et al. |
Cardiovascular effects of cannabinoids in conscious spontaneously hypertensive rats. |
2007 |
Br. J. Pharmacol. |
pmid:17700721
|
Matias I et al. |
Role and regulation of acylethanolamides in energy balance: focus on adipocytes and beta-cells. |
2007 |
Br. J. Pharmacol. |
pmid:17704823
|
Mendiguren A and Pineda J |
Effect of the CB(1) receptor antagonists rimonabant and AM251 on the firing rate of dorsal raphe nucleus neurons in rat brain slices. |
2009 |
Br. J. Pharmacol. |
pmid:19845674
|
Herradón E et al. |
Characterization of the vasorelaxant mechanisms of the endocannabinoid anandamide in rat aorta. |
2007 |
Br. J. Pharmacol. |
pmid:17704831
|
Zakrzeska A et al. |
A cannabinoid receptor, sensitive to O-1918, is involved in the delayed hypotension induced by anandamide in anaesthetized rats. |
2010 |
Br. J. Pharmacol. |
pmid:20105178
|
Ho WS and Randall MD |
Endothelium-dependent metabolism by endocannabinoid hydrolases and cyclooxygenases limits vasorelaxation to anandamide and 2-arachidonoylglycerol. |
2007 |
Br. J. Pharmacol. |
pmid:17245358
|
Whyte LS et al. |
Cannabinoids and bone: endocannabinoids modulate human osteoclast function in vitro. |
2012 |
Br. J. Pharmacol. |
pmid:21649637
|
Izzo AA et al. |
Effect of vanilloid drugs on gastrointestinal transit in mice. |
2001 |
Br. J. Pharmacol. |
pmid:11264233
|
Makwana R et al. |
Pharmacological characterization of cannabinoid receptor activity in the rat-isolated ileum myenteric plexus-longitudinal muscle preparation. |
2010 |
Br. J. Pharmacol. |
pmid:20233228
|
Thors L et al. |
Biochanin A, a naturally occurring inhibitor of fatty acid amide hydrolase. |
2010 |
Br. J. Pharmacol. |
pmid:20590565
|
Mukhopadhyay P et al. |
CB1 cannabinoid receptors promote oxidative/nitrosative stress, inflammation and cell death in a murine nephropathy model. |
2010 |
Br. J. Pharmacol. |
pmid:20590569
|
Rajesh M et al. |
Cannabinoid-1 receptor activation induces reactive oxygen species-dependent and -independent mitogen-activated protein kinase activation and cell death in human coronary artery endothelial cells. |
2010 |
Br. J. Pharmacol. |
pmid:20590572
|
Wheal AJ et al. |
Vasorelaxation to N-oleoylethanolamine in rat isolated arteries: mechanisms of action and modulation via cyclooxygenase activity. |
2010 |
Br. J. Pharmacol. |
pmid:20590573
|
Gutierrez-Lopez MD et al. |
Involvement of 2-arachidonoyl glycerol in the increased consumption of and preference for ethanol of mice treated with neurotoxic doses of methamphetamine. |
2010 |
Br. J. Pharmacol. |
pmid:20590579
|
Jamshidi N and Taylor DA |
Anandamide administration into the ventromedial hypothalamus stimulates appetite in rats. |
2001 |
Br. J. Pharmacol. |
pmid:11704633
|
Evans RM et al. |
Modulation of sensory neuron potassium conductances by anandamide indicates roles for metabolites. |
2008 |
Br. J. Pharmacol. |
pmid:18376419
|
Solinas M et al. |
The endocannabinoid system in brain reward processes. |
2008 |
Br. J. Pharmacol. |
pmid:18414385
|
Smith PJ and McQueen DS |
Anandamide induces cardiovascular and respiratory reflexes via vasosensory nerves in the anaesthetized rat. |
2001 |
Br. J. Pharmacol. |
pmid:11588121
|
Kawahara H et al. |
Inhibition of fatty acid amide hydrolase unmasks CB1 receptor and TRPV1 channel-mediated modulation of glutamatergic synaptic transmission in midbrain periaqueductal grey. |
2011 |
Br. J. Pharmacol. |
pmid:21175570
|
De Petrocellis L et al. |
Effects of cannabinoids and cannabinoid-enriched Cannabis extracts on TRP channels and endocannabinoid metabolic enzymes. |
2011 |
Br. J. Pharmacol. |
pmid:21175579
|
Stanford SJ et al. |
Identification of two distinct vasodilator pathways activated by ATP in the mesenteric bed of the rat. |
2001 |
Br. J. Pharmacol. |
pmid:11454655
|
Randall MD |
The cardiovascular actions of anandamide: more targets? |
2005 |
Br. J. Pharmacol. |
pmid:15834438
|
Kwolek G et al. |
Central and peripheral components of the pressor effect of anandamide in urethane-anaesthetized rats. |
2005 |
Br. J. Pharmacol. |
pmid:15834445
|
Mang CF et al. |
Differential effects of anandamide on acetylcholine release in the guinea-pig ileum mediated via vanilloid and non-CB1 cannabinoid receptors. |
2001 |
Br. J. Pharmacol. |
pmid:11522608
|
Jonsson KO et al. |
Effects of homologues and analogues of palmitoylethanolamide upon the inactivation of the endocannabinoid anandamide. |
2001 |
Br. J. Pharmacol. |
pmid:11498512
|
Li Q et al. |
Electrophysiological effects of anandamide on rat myocardium. |
2009 |
Br. J. Pharmacol. |
pmid:20050190
|
Underdown NJ et al. |
Anandamide reduces infarct size in rat isolated hearts subjected to ischaemia-reperfusion by a novel cannabinoid mechanism. |
2005 |
Br. J. Pharmacol. |
pmid:16158067
|
Mechoulam R |
Plant cannabinoids: a neglected pharmacological treasure trove. |
2005 |
Br. J. Pharmacol. |
pmid:16205721
|
Zygmunt PM et al. |
Studies on the effects of anandamide in rat hepatic artery. |
1997 |
Br. J. Pharmacol. |
pmid:9422814
|
Thomas A et al. |
Evidence that the plant cannabinoid Delta9-tetrahydrocannabivarin is a cannabinoid CB1 and CB2 receptor antagonist. |
2005 |
Br. J. Pharmacol. |
pmid:16205722
|
Scherma M et al. |
The anandamide transport inhibitor AM404 reduces the rewarding effects of nicotine and nicotine-induced dopamine elevations in the nucleus accumbens shell in rats. |
2012 |
Br. J. Pharmacol. |
pmid:21557729
|
Aquila S et al. |
Rimonabant (SR141716) induces metabolism and acquisition of fertilizing ability in human sperm. |
2010 |
Br. J. Pharmacol. |
pmid:20067470
|
Lever IJ and Malcangio M |
CB(1) receptor antagonist SR141716A increases capsaicin-evoked release of Substance P from the adult mouse spinal cord. |
2002 |
Br. J. Pharmacol. |
pmid:11786475
|
Ishac EJ et al. |
Inhibition of exocytotic noradrenaline release by presynaptic cannabinoid CB1 receptors on peripheral sympathetic nerves. |
1996 |
Br. J. Pharmacol. |
pmid:8864538
|
Mair KM et al. |
Interaction between anandamide and sphingosine-1-phosphate in mediating vasorelaxation in rat coronary artery. |
2010 |
Br. J. Pharmacol. |
pmid:20718749
|
Moezi L et al. |
Anandamide mediates hyperdynamic circulation in cirrhotic rats via CB(1) and VR(1) receptors. |
2006 |
Br. J. Pharmacol. |
pmid:17043671
|
Bisogno T et al. |
Molecular targets for cannabidiol and its synthetic analogues: effect on vanilloid VR1 receptors and on the cellular uptake and enzymatic hydrolysis of anandamide. |
2001 |
Br. J. Pharmacol. |
pmid:11606325
|
Li H et al. |
Inhibition of fatty acid amide hydrolase activates Nrf2 signalling and induces heme oxygenase 1 transcription in breast cancer cells. |
2013 |
Br. J. Pharmacol. |
pmid:23347118
|
Oliveira L et al. |
Effects of some isoprostanes on the human umbilical artery in vitro. |
2000 |
Br. J. Pharmacol. |
pmid:10711349
|
Steffens M et al. |
Cannabinoid CB1 receptor-mediated modulation of evoked dopamine release and of adenylyl cyclase activity in the human neocortex. |
2004 |
Br. J. Pharmacol. |
pmid:14993102
|
Evans RM et al. |
Multiple actions of anandamide on neonatal rat cultured sensory neurones. |
2004 |
Br. J. Pharmacol. |
pmid:15023857
|
Stein EA et al. |
Physiological and behavioural effects of the endogenous cannabinoid, arachidonylethanolamide (anandamide), in the rat. |
1996 |
Br. J. Pharmacol. |
pmid:8872363
|
Thors L et al. |
Inhibition of fatty acid amide hydrolase by kaempferol and related naturally occurring flavonoids. |
2008 |
Br. J. Pharmacol. |
pmid:18552875
|
Izzo AA et al. |
Peripheral endocannabinoid dysregulation in obesity: relation to intestinal motility and energy processing induced by food deprivation and re-feeding. |
2009 |
Br. J. Pharmacol. |
pmid:19371345
|
Ligresti A et al. |
New potent and selective inhibitors of anandamide reuptake with antispastic activity in a mouse model of multiple sclerosis. |
2006 |
Br. J. Pharmacol. |
pmid:16284631
|
Holt S et al. |
Effects of pH on the inhibition of fatty acid amidohydrolase by ibuprofen. |
2001 |
Br. J. Pharmacol. |
pmid:11399668
|
O'Brien LD et al. |
Anandamide transport inhibition by ARN272 attenuates nausea-induced behaviour in rats, and vomiting in shrews (Suncus murinus). |
2013 |
Br. J. Pharmacol. |
pmid:23991698
|
Ho WS et al. |
'Entourage' effects of N-palmitoylethanolamide and N-oleoylethanolamide on vasorelaxation to anandamide occur through TRPV1 receptors. |
2008 |
Br. J. Pharmacol. |
pmid:18695637
|
Ghafouri N et al. |
Inhibition of monoacylglycerol lipase and fatty acid amide hydrolase by analogues of 2-arachidonoylglycerol. |
2004 |
Br. J. Pharmacol. |
pmid:15492019
|
Lee MG et al. |
Effect of olvanil and anandamide on vagal C-fiber subtypes in guinea pig lung. |
2005 |
Br. J. Pharmacol. |
pmid:16056239
|
Movahed P et al. |
Vascular effects of anandamide and N-acylvanillylamines in the human forearm and skin microcirculation. |
2005 |
Br. J. Pharmacol. |
pmid:15997233
|
Plane F et al. |
Evidence that anandamide and EDHF act via different mechanisms in rat isolated mesenteric arteries. |
1997 |
Br. J. Pharmacol. |
pmid:9283682
|
Gaskari SA et al. |
Role of endocannabinoids in the pathogenesis of cirrhotic cardiomyopathy in bile duct-ligated rats. |
2005 |
Br. J. Pharmacol. |
pmid:16025138
|
Kagaya M et al. |
Characterization of the anandamide induced depolarization of guinea-pig isolated vagus nerve. |
2002 |
Br. J. Pharmacol. |
pmid:12183329
|
Geraghty DP and Mazzone SB |
Respiratory actions of vanilloid receptor agonists in the nucleus of the solitary tract: comparison of resiniferatoxin with non-pungent agents and anandamide. |
2002 |
Br. J. Pharmacol. |
pmid:12411424
|
De Petrocellis L et al. |
Actions of two naturally occurring saturated N-acyldopamines on transient receptor potential vanilloid 1 (TRPV1) channels. |
2004 |
Br. J. Pharmacol. |
pmid:15289293
|